Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Debt Ratio: 2009-2025

Historic Debt Ratio for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to 0.16.

  • Aytu Biopharma's Debt Ratio rose 59.63% to 0.20 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63, marking a year-over-year increase of 23.60%. This contributed to the annual value of 0.16 for FY2025, which is 43.01% up from last year.
  • Latest data reveals that Aytu Biopharma reported Debt Ratio of 0.16 as of FY2025, which was up 43.01% from 0.11 recorded in FY2024.
  • Aytu Biopharma's Debt Ratio's 5-year high stood at 0.16 during FY2025, with a 5-year trough of 0.06 in FY2021.
  • Moreover, its 3-year median value for Debt Ratio was 0.12 (2023), whereas its average is 0.13.
  • Its Debt Ratio has fluctuated over the past 5 years, first surged by 889.97% in 2021, then fell by 9.27% in 2023.
  • MRY analysis of 5 years shows Aytu Biopharma's Debt Ratio stood at 0.06 in 2021, then skyrocketed by 107.29% to 0.13 in 2022, then dropped by 9.27% to 0.12 in 2023, then decreased by 5.77% to 0.11 in 2024, then soared by 43.01% to 0.16 in 2025.
  • Its last three reported values are 0.16 in FY2025, 0.11 for FY2024, and 0.12 during FY2023.